Baker Bros. Capital (GP), LLC

Director at INCYTE CORP · on record since Feb 2, 2007
10% owner at Aceragen, Inc. · on record since Mar 28, 2006
Director at SYNAGEVA BIOPHARMA CORP · on record since Feb 2, 2007
10% owner at SYNAGEVA BIOPHARMA CORP · on record since Feb 2, 2007
10% owner at Ardea Biosciences, Inc./DE · on record since Feb 28, 2006
10% owner at VIROPHARMA INC · on record since Mar 1, 2006
10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 20, 2006
10% owner at ALLOS THERAPEUTICS INC · on record since Nov 17, 2006
Director at GENOMIC HEALTH INC · on record since Feb 21, 2007
10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
Director at Seagen Inc. · on record since Feb 16, 2007
10% owner at Seagen Inc. · on record since Feb 16, 2007
Director at NEUROGEN CORP · on record since Feb 2, 2007
10% owner at NEUROGEN CORP · on record since Feb 2, 2007
10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
10% owner at Synvista Therapeutics, Inc. · on record since Aug 3, 2007
10% owner at INCYTE CORP · on record since Dec 19, 2007
10% owner at · on record since Oct 28, 2009
10% owner at · on record since Apr 28, 2010
10% owner at · on record since Jul 29, 2010
Director at · on record since Jul 5, 2011

Insider trading activity of Baker Bros. Capital (GP), LLC

Transactions on record: 193; since Sep 23, 2003

Open-market buys: 101; $4.6M

Open-market sells: 50; $2M

Companies traded: 14; last filing Jan 31, 2012

Figures computed from official regulatory filings — .

Companies where Baker Bros. Capital (GP), LLC has traded

3 tx · $42K · Jan 31, 2012
33 tx · $937K · Jan 4, 2012
13 tx · $976.5K · Jul 5, 2011
17 tx · $820.4K · Jul 5, 2011
2 tx · $90K · Apr 26, 2011
1 tx · $6.8K · Mar 31, 2011
26 tx · $64.7K · Aug 17, 2009
6 tx · $159.1K · Jun 1, 2009
46 tx · $1.2M · May 15, 2009
12 tx · $7.9K · Jan 23, 2009
23 tx · $491.9K · Sep 30, 2008
4 tx · $2.6M · Apr 15, 2008
1 tx · $57.3 · Apr 8, 2008
6 tx · $439.4K · Sep 14, 2004

Track record of Baker Bros. Capital (GP), LLC

Statistical track record

Free account

Open-market buys: 123

Last buy: Apr 24, 2011

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Baker Bros. Capital (GP), LLC

Co-insiders of Baker Bros. Capital (GP), LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Diadexus, Inc.Listing unverified	Jan 31, 2012	Sell	-59,340	0.22 USD	$13.1K		SEC
Diadexus, Inc.Listing unverified	Jan 20, 2012	Sell	-20,000	0.20 USD	$4K		SEC
Diadexus, Inc.Listing unverified	Jan 20, 2012	Sell	-118,800	0.21 USD	$24.9K		SEC
Seagen Inc.Listing unverified	Jan 4, 2012	OtherD (derivative)	-68,006	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Seagen Inc.Listing unverified	Jan 4, 2012	Other	68,006	6.25 USD	$425K		SEC
Ardea Biosciences, Inc./DEListing unverified	Jul 5, 2011	Other	-9,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INCYTE CORPListing on record	Jul 5, 2011	Other	-11,664	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Seagen Inc.Listing unverified	Jul 5, 2011	Other	-10,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HERON THERAPEUTICS, INC. /DE/Listing on record	Apr 26, 2011	BuyD (derivative)	300	300.00 USD	$90K	Cluster	SEC
HERON THERAPEUTICS, INC. /DE/Listing on record	Apr 26, 2011	BuyD (derivative)	600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
AUXILIUM PHARMACEUTICALS INCListing unverified	Mar 31, 2011	Buy	309	21.98 USD	$6.8K	conv 39ClusterFirst in 12mo	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-3,938	14.09	$55.5K	Unusual size	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-6,053	14.08	$85.2K	Unusual size	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-956	14.00	$13.4K		SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-1,856	14.00	$26K		SEC
GENOMIC HEALTH INCListing unverified	Aug 17, 2009	Buy	33	19.99	$659.7	conv 27Cluster	SEC
GENOMIC HEALTH INCListing unverified	Aug 17, 2009	Buy	1	19.60	$19.6	conv 25Cluster	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-3,124	3.89	$12.2K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-8,067	3.86	$31.1K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-1,500	4.30	$6.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-7,726	4.12	$31.8K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-6,174	4.45	$27.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-11,128	4.50	$50.1K	Unusual size	SEC
Seagen Inc.Listing unverified	May 20, 2009	Buy	3,710	9.72	$36.1K	conv 25Cluster	SEC
VIROPHARMA INCListing unverified	May 15, 2009	Buy	190	5.46	$1K	conv 25Cluster	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Diadexus, Inc.Listing unverified	Jan 31, 2012	Sell	-59,340	0.22 USD	$13.1K		SEC
Diadexus, Inc.Listing unverified	Jan 20, 2012	Sell	-20,000	0.20 USD	$4K		SEC
Diadexus, Inc.Listing unverified	Jan 20, 2012	Sell	-118,800	0.21 USD	$24.9K		SEC
Seagen Inc.Listing unverified	Jan 4, 2012	OtherD (derivative)	-68,006	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Seagen Inc.Listing unverified	Jan 4, 2012	Other	68,006	6.25 USD	$425K		SEC
Ardea Biosciences, Inc./DEListing unverified	Jul 5, 2011	Other	-9,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INCYTE CORPListing on record	Jul 5, 2011	Other	-11,664	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Seagen Inc.Listing unverified	Jul 5, 2011	Other	-10,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HERON THERAPEUTICS, INC. /DE/Listing on record	Apr 26, 2011	BuyD (derivative)	300	300.00 USD	$90K	Cluster	SEC
HERON THERAPEUTICS, INC. /DE/Listing on record	Apr 26, 2011	BuyD (derivative)	600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
AUXILIUM PHARMACEUTICALS INCListing unverified	Mar 31, 2011	Buy	309	21.98 USD	$6.8K	conv 39ClusterFirst in 12mo	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-3,938	14.09	$55.5K	Unusual size	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-6,053	14.08	$85.2K	Unusual size	SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-956	14.00	$13.4K		SEC
INCYTE CORPListing on record	Aug 11, 2010	Sell	-1,856	14.00	$26K		SEC
GENOMIC HEALTH INCListing unverified	Aug 17, 2009	Buy	33	19.99	$659.7	conv 27Cluster	SEC
GENOMIC HEALTH INCListing unverified	Aug 17, 2009	Buy	1	19.60	$19.6	conv 25Cluster	SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-3,124	3.89	$12.2K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-8,067	3.86	$31.1K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-1,500	4.30	$6.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-7,726	4.12	$31.8K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-6,174	4.45	$27.5K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 1, 2009	Sell	-11,128	4.50	$50.1K	Unusual size	SEC
Seagen Inc.Listing unverified	May 20, 2009	Buy	3,710	9.72	$36.1K	conv 25Cluster	SEC
VIROPHARMA INCListing unverified	May 15, 2009	Buy	190	5.46	$1K	conv 25Cluster	SEC